Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -544.8%
March 31, 2026 -602.8%
December 31, 2025 -392.7%
September 30, 2025 -442.5%
June 30, 2025 -479.5%
March 31, 2025 -474.4%
December 31, 2024 -550.6%
September 30, 2024 -529.0%
June 30, 2024 -743.8%
March 31, 2024 -674.5%
December 31, 2023 -425.8%
September 30, 2023 -506.7%
June 30, 2023 -584.6%
March 31, 2023 -591.1%
Date Value
December 31, 2022 -583.6%
September 30, 2022 -606.3%
June 30, 2022 -630.1%
March 31, 2022 -713.9%
December 31, 2021 -651.0%
September 30, 2021 -857.1%
June 30, 2021 -1.25K%
March 31, 2021 -26.50K%
December 31, 2020 -3.85K%
September 30, 2020 -11.43K%
June 30, 2020 -8.62K%
March 31, 2020 -3.10K%
December 31, 2019 -8.87K%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. -2.80%
Medpace Holdings, Inc. 17.16%
Avantor, Inc. 2.25%
Personalis, Inc. -141.7%
Adaptive Biotechnologies Corp. -55.82%